About Us

OUR MISSION

Our mission is to help clients create value through realizing the promise of science and technology for the benefit of patients. We provide deep expertise across the pharmaceuticals and healthcare sectors, unparalleled insights from a global network of key opinion leaders and distinctive client service.

OUR LEADERSHIP TEAM

KHALED MUSALLAM
MD PhD

Khaled is Founder of EVIDA MEDICAL and is based in Dubai. He joined EVIDA MEDICAL from a clinical lead role in Oncology Global Development & Global Medical Affairs at Novartis, where he worked on key established and pipeline products. Khaled has deep therapeutic area expertise in hematology: he has over two hundred publications to his credit, has held Editorial and peer-review roles at several high impact journals and is considered a global key opinion leader in his own right. He has expertise across medical communications and research development and has led landmark consulting projects serving global pharmaceuticals clients and large academic centers. Khaled received his medical degree from the American University of Beirut and his PhD from the Leiden University Medical Center. He completed hematology/oncology research fellowships at the American University of Beirut Medical Center and the University of Milan.

KAIVAN KHAVANDI
MD MRes

Kaivan is EVIDA MEDICAL's Managing Director in London. He brings operational experience in healthcare and allied sectors, together with expertise in developing successful education and training activities across clinical medicine, academia and industry. Kaivan’s research interests are in clinical pharmacology, with a focus on hypertension, cardiometabolic disorders and nephropathy. He continues to be involved with clinical and academic cardiovascular medicine at the British Heart Foundation Center at King's College London, as well as the Wellcome Trust Clinical Research Facility at the University of Manchester from where he received his medical degree.

REGULATORY COMPLIANCE & ETHICS

Our policies and practice meet the requirements of all applicable regulations and guidelines. We adhere to the standard of relevant policies set out by the following bodies:

Government Organizations

  • The US Food and Drug administration (FDA) Regulations Relating to Clinical Trials and Industry-Supported Scientific and Educational Activities
  • The International Conference on Harmonization (ICH) – Good Clinical Practice (GCP) Consolidated Guidance
  • The European Medicines Agency (EMA) EU Clinical Trials Directive

International Privacy Laws

  • The US Health Insurance Portability and Accountability Act (HIPAA)
  • The EU Data Protection Directive

Communication Guidelines

  • The Pharmaceutical Research and Manufacturers of America (PhRMA) Principles on Conduct of Clinical Trials and Communication of Clinical Trial Results
  • American Medical Association (AMA) Code of Medical Ethics
  • The Advanced Medical Technology Association (AdvaMed) Code of Ethics on Interaction with Health Care Professionals
  • The International Committee of Medical Journal Editors (ICJME)
  • The American Medical Writers Associations (AMWA)
  • The European Medical Writers Association (EMWA)
  • The Medical Publishing Insights and Practices (MPIP) Initiative
  • The Committee on Publication Ethics (COPE)
  • The Council of Science Editors
  • The International Society for Medical Publication Professionals (ISMPP) Good publication practice for communicating company sponsored medical research: the GPP2 guidelines
  • Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support
  • Digital Health Coalition (DHC) Social Media Guiding Principles and Best Practices

Reporting Guidelines

  • Consolidated Standards Of Reporting Trials (CONSORT) Statement
  • Strengthening the Reporting of OBservational studies in Epidemiology (STROBE)
  • Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
  • Standards for Reporting of Diagnostic Accuracy (STARD)
  • Consolidated criteria for REporting Qualitative research (COREQ)
  • Enhancing Transparency in REporting the synthesis of Qualitative research (ENTREQ)
  • Standards for Quality Improvement Reporting Excellence (SQUIRE) Publication Guidelines for Quality Improvement in Health Care
  • Consolidated Health Economic Evaluation Reporting Standards (CHEERS)
  • Consensus-based clinical CAse REporting guideline development (CARE)
  • The Statistical Analyses and Methods in the Published Literature (SAMPL) Guidelines